“…The process of amyloidosis is caused by the misfolding and aggregation of proteins, and it leads to many known diseases such as Alzheimer’s disease (AD), Parkinson’s disease, type-2 diabetes, Huntington’s disease, and spongiform encephalopathy. − Alzheimer’s is the most common form of neurodegenerative disease in which amyloid fibril plaques have been found to be formed in the brains of concerned patients. − The fibril plaques mainly consist of highly ordered β-sheet-rich structures in which the β sheets are arranged perpendicularly to the fibril axis. ,,, In AD, amyloid-β (Aβ) peptides (mainly Aβ(1–40) and Aβ(1–42)), which are produced through endoproteolysis of the β-amyloid precursor protein (βAPP) by β- and γ-secretase sequentially, aggregate and get deposited in the human brain, leading to the death of active brain cells. ,,− Of the two forms, Aβ(1–42) has been found to be neurologically more toxic than Aβ(1–40). , It has been reported that low-molecular-weight soluble prefibrillar oligomers and protofibrils are more responsible for neurotoxicity. − There have been both experimental and theoretical studies which have looked at a variety of nanoparticles, − small peptides, and organic molecules − for the prevention of AD. Although the mechanism of amyloid formation is not yet fully resolved, ,− various experimental studies have proposed that the initial random coil or α-helical structure of Aβ(1–42) monomers first get converted to β-sheet structures which then assemble to form Aβ aggregates.…”